NVision Quantum Technologies

www.nvision-quantum.com

Formerly NVision Imaging Technologies GmbH

High-Tech Company

TECH VERTICALS

Cancer, Diagnostics, Healthtech, Imaging, Life Sciences, Medical Imaging, MedTech, Monitoring, MRI, Quantum Technology

General Data

Sector	Medical Devices
Company Stage:	Revenue Growth
Established	2015
Number of Employees	143

DESCRIPTION

NVision is a quantum technology company developing quantum systems for healthcare and life sciences. The company’s platforms combine quantum-enhanced MRI and quantum computing to help researchers better understand disease, design new therapies, and measure treatment response in living systems. NVision is bringing quantum technologies out of the lab and into real-world healthcare applications.

TECHNOLOGY

NVision’s technology is based on engineering and controlling the quantum properties of organic molecules. Its POLARIS platform works alongside existing MRI scanners to increase the MRI signal of metabolic imaging agents by more than 10,000 times, enabling real-time visibility into disease metabolism and treatment response. NVision is also developing PIQC, a quantum computing platform that applies the company’s molecular quantum approach to organic molecule-based qubits integrated on photonic chips. Together, POLARIS and PIQC form NVision’s end-to-end quantum-based approach to designing and validating therapies.

Products and Phases

Product	Phase
N/A	Approved
A platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Physicians, scientists.

	BUSINESS MODEL
	B2B

COMPETITORS

Caperay , Custom Surgical , Ezra

CONTACT INFO

Expand / Collapse All

Main Address: Ulm, Germany

Address	2 Wolfgang-Paul-St.
City	Ulm
Country	Germany
Zip	89081

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Sella Brosh	CEO
Mr. Ilai Schwarz	CTO & Co-Founder
Mr. Stephan Knecht	AVP, Technology Development
Mr. Vincent Guyot	VP, Head of Development MR Hyperolarization
Prof. Martin Plenio	Scientific Advisor & Co-Founder
Ms. Mor Schwartz	AVP, Head of Operations & Corporate Services

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	General Partner & Founder, Playground Global
abC Defghij	Observer	Managing Partner, Entree Capital
abC Defghij	Observer	Partner, Matterwave Ventures

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

May. 13, 2026

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	High-Tech Company	abCDe	Led the round

Debt Financing

May. 13, 2026

Revenue Growth

abCDe

First Round - Extended

Dec. 20, 2024

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Other	abCDe	Led the round

Debt Financing

Oct. 10, 2024

Revenue Growth

abCDe

First Round

Jun. 22, 2023

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Investment Company	abCDe

Seed

Jan. 01, 2018

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Nov. 01, 2024

Revenue Growth

abCDe

R&D Grant

Jul. 01, 2024

Revenue Growth

abCDe

R&D Grant

Apr. 01, 2024

Revenue Growth

abCDe

R&D Grant

Apr. 01, 2023

Initial Revenues

abCDe

R&D Grant

Oct. 01, 2022

Initial Revenues

abCDe

R&D Grant

Jan. 01, 2022

Initial Revenues

abCDe

R&D Grant

Aug. 01, 2021

R&D

abCDe

R&D Grant

Oct. 01, 2018

R&D

abCDe

R&D Grant

Aug. 01, 2018

R&D

abCDe

R&D Grant

Jun. 01, 2018

R&D

abCDe

R&D Grant

Jan. 01, 2018

Seed

abCDe

R&D Grant

Jan. 01, 2016

Seed

abCDe

Last Updated:	abCDe
IVC Number:	abCDe